cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Novavax Inc
218 own
151 watching
Current Price
$10.91
$0.26
(2.44%)
logo-nvax
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
856.18M
52-Week High
52-Week High
101.39
52-Week Low
52-Week Low
8.75
Average Volume
Average Volume
6.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization856.18M
icon52-Week High101.39
icon52-Week Low8.75
iconAverage Volume6.17M
iconDividend Yield--
iconP/E Ratio--
What does the Novavax Inc do?
Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Novavax Inc make?
News & Events about Novavax Inc.
PR Newswire
1month ago
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates PR Newswire GAITHERSBURG, Md., Dec. 30, 2022...
CNW Group - News Releases
1month ago
Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes Canada NewsWire GAITHERSBURG, Md., Dec. 15, 2022 GAITHERSBURG, Md., Dec. 15, 2022 /CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology...
CNW Group - News Releases
1month ago
Novavax Announces Pricing of $65 Million Public Offering of Common Stock Novavax Announces Pricing of $65 Million Public Offering of Common Stock Canada NewsWire GAITHERSBURG, Md., Dec. 15, 2022 GAITHERSBURG, Md., Dec. 15, 2022 /CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company...
PR Newswire
1month ago
Novavax Announces Pricing of $65 Million Public Offering of Common Stock Novavax Announces Pricing of $65 Million Public Offering of Common Stock PR Newswire GAITHERSBURG, Md., Dec. 15, 2022 GAITHERSBURG, Md., Dec. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company...
Frequently Asked Questions
Frequently Asked Questions
What is Novavax Inc share price today?
plus_minus_icon
Can Indians buy Novavax Inc shares?
plus_minus_icon
How can I buy Novavax Inc shares from India?
plus_minus_icon
Can Fractional shares of Novavax Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Novavax Inc stocks?
plus_minus_icon
What is today’s traded volume of Novavax Inc?
plus_minus_icon
What is today’s market capitalisation of Novavax Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Novavax Inc?
plus_minus_icon
What percentage is Novavax Inc down from its 52-Week High?
plus_minus_icon
What percentage is Novavax Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.91
$0.26
(2.44%)
logo-nvax
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00